Please login to the form below

Not currently logged in
Email:
Password:

Orrin Pollard joins behavioural change agency Hamell

Theformer DDB Remedy chairman takes up an executive creative director role

Hamell Orrin PollardHamell has appointed Orrin Pollard as a partner and executive creative director in a role that will see him help launch new communications division Hamell Ignyte.

Pollard has been chairman at DDB remedy for 11 years, prior to which he was director and creative director at UK healthcare advertising agency Leavold Pollard Bardsley for eight years.

He said: “Many agencies talk about changing behaviour, but few actually have the evidence to back it up. “This is where Hamell Ignyte differs, because through our behavioural research division Hamell Spark, [and its] unique, validated methodology, we are able to get under the skin and into the minds of our target audiences to really discover their motivators and behavioural drivers.”

London-based agency Hamell was formed in 2008 and its new comms division will be driven by Pollard and Hamell's managing director Fiona Hammond and clinical director Alison Carr.

Commenting on Pollard's appointment, Hammond said: “We are absolutely thrilled that Orrin is joining us here at Hamell. He brings with him a wealth of experience, and his proven expertise will enable us to realise our vision of creating innovative communication solutions that facilitate real and lasting behavioural change.

“This is a step forward for Hamell and comes hot on the heels of some major new business wins in behavioural research. We are excited to be growing our full service agency and translating more of our in-depth behavioural insights into communications supported by memorable, engaging creative.”

10th November 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics